Development of CRISPR/Cas Genome Editing as a Treatment for Ataxia Telangiectasia

Project: Research

Project Details

StatusFinished
Effective start/end date1/11/1711/03/24

Funding

  • Action for AT: £200,000.00
  • Action for AT: £40,000.00